Priti Patel's most recent trade in MDU Resources Group Inc was a trade of 4,849 Common Stock done . Disclosure was reported to the exchange on Nov. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MDU Resources Grp Inc | Priti R. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2025 | 4,849 | 4,849 (0%) | 0% | 0 | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 1,502 | 34,388 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2025 | 1,502 | 14,407 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.87 per share. | 03 Oct 2025 | 538 | 13,869 (0%) | 0% | 28.9 | 15,532 | Common Stock |
| National Vision Holdings Inc | Priti Patel | General Manager | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 24,672 | 35,890 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,363 | 14,556 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,363 | 12,321 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,988 | 11,218 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 2,988 | 14,133 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.71 per share. | 01 Mar 2025 | 1,382 | 10,939 (0%) | 0% | 12.7 | 17,565 | Common Stock |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 01 Mar 2025 | 1,228 | 12,905 (0%) | 0% | 12.7 | 15,546 | Common Stock |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 350 | 14,206 | - | - | Restricted Stock Units | |
| National Vision Holdings Inc | Priti Patel | General Manager | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 350 | 11,289 (0%) | 0% | - | Common Stock | |
| National Vision Holdings Inc | Priti Patel | General Manager | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.71 per share. | 01 Mar 2025 | 144 | 11,145 (0%) | 0% | 12.7 | 1,830 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Former Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 10,000 | 0 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Former Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 10,000 | 41,082 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Priti Patel | Former Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 31 Mar 2023 | 3,769 | 37,313 (0%) | 0% | 0.7 | 2,608 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 35,000 | 35,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 35,000 | 45,462 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 01 Feb 2023 | 14,380 | 31,082 (0%) | 0% | 0.6 | 8,588 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2022 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 10,000 | 12,000 (0%) | 0% | 0 | Common Stock | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2022 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 1.22 per share. | 30 Apr 2022 | 5,538 | 6,462 (0%) | 0% | 1.2 | 6,749 | Common Stock |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 70,000 | 70,000 | - | - | Restricted Stock Units | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 475,000 | 475,000 | - | - | Stock Option (Right to Buy) | |
| Neoleukin Therapeutics Inc | Priti Patel | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 20,000 | 20,000 | - | - | Restricted Stock Units |